Navigation Links
Cell Therapeutics Awarded $977,917 in Grants Under the Therapeutic Discovery Tax Credit Program
Date:11/2/2010

SEATTLE, Nov. 2, 2010 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that it has been awarded $977,917 in grants under the Therapeutic Discovery Tax Credit program that was enacted under the U.S. government's Patient Protection and Affordable Care Act. The program targets projects that show potential to produce new therapies, address unmet medical needs, reduce the long-term growth of health care costs and advance the goal of curing cancer. CTI was awarded the grants for CTI's programs pixantrone, OPAXIO, brostallicin and bisplatinates which are all focused in the area of oncology.  

"We are pleased that the U.S. Department of Health and Human Services recognizes the potential impact that CTI's research and drugs could have for patients and specifically in advancing the effort to make cancer more treatable," said James A. Bianco, M.D., CEO of Cell Therapeutics. "This program is also recognition of the importance of the contribution the biotechnology industry is making to U.S. healthcare. These grants will allow CTI to further advance its product candidates in an effort to treat areas that have significant unmet medical needs."

About Cell Therapeutics, Inc.Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.

Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_alert

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the market price of CTI's securities. Specifically, the risks and uncertainties associated with
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial
2. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for Pixuvri®
3. Shield Therapeutics Signs Agreement With AOP Orphan for ST10-021
4. Echo Therapeutics to Present at the LifeTech Capital 1st Annual Miami Medical Investors Conference
5. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
6. Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease
7. Columbia University Students Learn About Pharmacy Benefit Management From Prime Therapeutics President and CEO
8. Cornerstone Therapeutics to Host Third Quarter 2010 Conference Call
9. Cell Therapeutics Third Quarter Net Loss Decreases by 68% in 2010 Compared to 2009
10. Veteran Pharmaceutical Executives Form New American Therapeutics, Inc.
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Inc. (NASDAQ: QCOR ) today reported financial results ... Ended 06/30/14Three Months Ended 06/30/13 ,  Percentage ChangeGAAP Net Sales ... Net Sales , $278.8 Million , $196.1 Million , ... $1.12 , 37% Non-GAAP Diluted EPS , ... Months Ended 06/30/14Six Months Ended 06/30/13 ,  Percentage ChangeNet Sales ...
(Date:7/24/2014)... 24, 2014 Cancer patients in the west of ... cancer treatment closer to home when a new radiotherapy center ... Medical Systems (NYSE: VAR ) has been selected ... in June for four TrueBeam™ medical linear accelerators. ... and efficient radiotherapy and radiosurgery treatments, will replace older treatment ...
(Date:7/24/2014)...  Bruin Biometrics (BBI), a pioneer in biometric-sensor ... weeks of clinical briefings to over 200 pressure ... substantial concurrence on both the clinical validity of ... BBI,s SEM Scanner. "From our ... drawn from the European Wound Management Association (EWMA) ...
Breaking Medicine Technology:Questcor Reports Record Second Quarter Financial Results 2Questcor Reports Record Second Quarter Financial Results 3Questcor Reports Record Second Quarter Financial Results 4Questcor Reports Record Second Quarter Financial Results 5Questcor Reports Record Second Quarter Financial Results 6Questcor Reports Record Second Quarter Financial Results 7Questcor Reports Record Second Quarter Financial Results 8Questcor Reports Record Second Quarter Financial Results 9Questcor Reports Record Second Quarter Financial Results 10Questcor Reports Record Second Quarter Financial Results 11Questcor Reports Record Second Quarter Financial Results 12Questcor Reports Record Second Quarter Financial Results 13Questcor Reports Record Second Quarter Financial Results 14Questcor Reports Record Second Quarter Financial Results 15Questcor Reports Record Second Quarter Financial Results 16Questcor Reports Record Second Quarter Financial Results 17Questcor Reports Record Second Quarter Financial Results 18Questcor Reports Record Second Quarter Financial Results 19Questcor Reports Record Second Quarter Financial Results 20Questcor Reports Record Second Quarter Financial Results 21Questcor Reports Record Second Quarter Financial Results 22Questcor Reports Record Second Quarter Financial Results 23Questcor Reports Record Second Quarter Financial Results 24Questcor Reports Record Second Quarter Financial Results 25Questcor Reports Record Second Quarter Financial Results 26Questcor Reports Record Second Quarter Financial Results 27Questcor Reports Record Second Quarter Financial Results 28Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 2Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 3Bruin Biometrics Secures Support of EU Scientific Community for its SEM Scanner Technology 2
... ADDISON, Texas, May 11, 2011 ULURU Inc. ... scheduled a conference call to discuss the first quarter ended March ... on Tuesday, May 17, 2011 at 9:00 a.m. Eastern Time. ... for international callers dial (850) 429-1388 (access code 23748#) five to ...
... May 11, 2011 HCB Health, one of the ... and the leading healthcare agency in the Southwest, won ... the 22nd annual Manny Awards, a national competition honoring ... for a consumer campaign supporting Sound Surgical Technologies, VASER® ...
Cached Medicine Technology:ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2011 and to Provide a Business Update 2HCB Health Wins Manny Award for Best Medical Device Campaign 2
(Date:7/24/2014)... Journal of Oral Implantology —Success of a ... the alveolar ridge—an indication of the amount of bone ... exist, each with their own advantages, to determine bone ... highlighted as a strategy for treating horizontally collapsed alveolar ... comparison of two commonly used techniques , the ...
(Date:7/24/2014)... bearing human breast tumors, exposure to dim light at ... drug tamoxifen, according to data published in Cancer ... Cancer Research. The negative effects of dim light exposure ... melatonin supplement during the night. , "Resistance to tamoxifen ... breast cancer," said Steven M. Hill, PhD, professor of ...
(Date:7/24/2014)... 2014 Vulnerable populations such as ... are disproportionately affected by food security, despite the ... the United States, according to a new report ... the Consolidated Appropriations Act, 2014 (P.L. 113-76), Congress ... Nutrition Service (FNS) to contract with a nonprofit ...
(Date:7/24/2014)... July 24, 2014 In a July 9th ... and founder of Lotus Blossom Consulting LLC , was ... Three Ways to Cut the High Cost of Infertility ... minimize costs is to maximize your chance of success from ... choosing a clinic. , “I am always happy to ...
(Date:7/24/2014)... appears to increase the risk for head and neck cancer ... with DM, but the risk of HNC in patients with ... cancer is the sixth most common type of cancer. It ... an estimated 650,000 new cancer cases and 350,000 cancer deaths ... Insurance Research Database to examine the risk of HNC in ...
Breaking Medicine News(10 mins):Health News:A Comparison of Graft Techniques for the Alveolar Ridge Prior to Oral Implant 2Health News:A Comparison of Graft Techniques for the Alveolar Ridge Prior to Oral Implant 3Health News:Exposure to dim light at night may make breast cancers resistant to tamoxifen 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 3Health News:Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood 2Health News:Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood 3
... has shown that a synthetic derivative of a common North ... living longer. ,University of Michigan scientist Richard ... called NDGA. ,While presenting the preliminary results of ... Association, he said that male mice fed a normal diet ...
... monsoons making a grand entry into Kerala, tourist resorts and ... The rainy season, experts say, is the best time for ... India, it has only in recent years that it has ... in the months June-August. ,According to ayurveda specialists, ...
... one hundred Long Island AARP members gathered today to rally ... 2007 Legislative Session in Albany that will help make ... phone works in an emergency. The AARP members took their ... tour of Nassau and Suffolk counties that stopped at more ...
... An awful lot of sexuality in Enrique Iglesias lyrics is apparently ... Spanish singer recently revealed that he was also a part of ... ,When asked if he thinks about sex more than other ... ,'No. I read that males think about sex every ...
... in Australia have relatively low rates of hospital use, ... health care, refugee health specialists said in the ... ,Deputy Director of the Melbourne-based Refugee Health Research ... in Victoria over the six financial years to June ...
... have hypothesized that the fetus can be exposed to ... the mother has been exposed, and this may have ... (e.g. eczema and asthma) later in an infants life). ... of an inability to detect antigen-specific T cells in ...
Cached Medicine News:Health News:Common Desert Shrub may Increase Longevity 2Health News:Ayurveda Resorts in Kerala Gear Up for the Monsoon Season 2Health News:Ayurveda Resorts in Kerala Gear Up for the Monsoon Season 3Health News:Long Island Seniors Rally for Rx Affordable Prescription Drugs and Cell Phone Protections 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: